drugset / Trial / NCT02202512

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

NCT02202512

Phase 1 Completed 53 enrolled Boehringer Ingelheim
RandomizedParallel-groupSingle-blindTreatment

Summary

Main objective is to investigate the measured glomerular filtration rate (mGFR) as assessed by iohexol clearance in healthy male normovolemic subjects after oral administration of single and repeated doses of BI 1060469, and BI 1021958. The secondary objective of this trial is to investigate the glomerular filtration rate (GFR) as assessed by 24 hours creatinine clearance in healthy male normovolemic subjects after oral administration of single and repeated doses of BI 1060469, and BI 1021958.

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1021958 Unknown Oral
Subject BI 1060469 Unknown Oral
Comparator Cimetidine Small molecule Oral
Comparator Naproxen Small molecule Oral

Indications

No indication recorded.